Duncan E. Hutcheon

778 total citations
45 papers, 450 citations indexed

About

Duncan E. Hutcheon is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Duncan E. Hutcheon has authored 45 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Nephrology. Recurrent topics in Duncan E. Hutcheon's work include Renal function and acid-base balance (6 papers), Pharmaceutical studies and practices (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Duncan E. Hutcheon is often cited by papers focused on Renal function and acid-base balance (6 papers), Pharmaceutical studies and practices (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Duncan E. Hutcheon collaborates with scholars based in United States, Canada and Egypt. Duncan E. Hutcheon's co-authors include Kenneth L. Duchin, Alexander Scriabine, Joseph F. Gardocki, Daniel L. Morris, G. D. Laubach, Edward J. Flynn, Heinz Rüdel, Russell N. Van Gelder, Sharon Pan and Martin Feuerman and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and JAMA.

In The Last Decade

Duncan E. Hutcheon

43 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duncan E. Hutcheon United States 13 86 76 65 43 42 45 450
Marc J. Bayer United States 13 61 0.7× 57 0.8× 57 0.9× 74 1.7× 47 1.1× 17 513
Theodore Koppányi United States 10 93 1.1× 82 1.1× 32 0.5× 57 1.3× 59 1.4× 51 494
Irwin B. Hanenson United States 13 224 2.6× 138 1.8× 106 1.6× 53 1.2× 36 0.9× 28 652
M. M. Reidenberg United States 12 80 0.9× 133 1.8× 51 0.8× 70 1.6× 48 1.1× 27 659
J Naestoft Denmark 14 162 1.9× 65 0.9× 23 0.4× 73 1.7× 98 2.3× 20 716
Philip Henschke Australia 12 31 0.4× 44 0.6× 57 0.9× 26 0.6× 36 0.9× 24 575
Mervin L. Clark United States 18 98 1.1× 63 0.8× 23 0.4× 86 2.0× 96 2.3× 50 899
J. A. Jansen Denmark 16 52 0.6× 87 1.1× 46 0.7× 118 2.7× 78 1.9× 30 656
Louis Wj Australia 14 150 1.7× 133 1.8× 57 0.9× 80 1.9× 103 2.5× 29 547
Harald Olsen Norway 16 62 0.7× 144 1.9× 84 1.3× 106 2.5× 60 1.4× 56 878

Countries citing papers authored by Duncan E. Hutcheon

Since Specialization
Citations

This map shows the geographic impact of Duncan E. Hutcheon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan E. Hutcheon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan E. Hutcheon more than expected).

Fields of papers citing papers by Duncan E. Hutcheon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan E. Hutcheon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan E. Hutcheon. The network helps show where Duncan E. Hutcheon may publish in the future.

Co-authorship network of co-authors of Duncan E. Hutcheon

This figure shows the co-authorship network connecting the top 25 collaborators of Duncan E. Hutcheon. A scholar is included among the top collaborators of Duncan E. Hutcheon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan E. Hutcheon. Duncan E. Hutcheon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutcheon, Duncan E.. (2010). Chloroform Anesthesia and the Saville Kent Murder in 1860. American Journal of Therapeutics. 17(2). 226–231. 3 indexed citations
2.
Hutcheon, Duncan E.. (1996). DISPOSITION, METABOLISM, AND TOXICITY OF METHYL TERTIARY BUTYL ETHER, AN OXYGENATE FOR REFORMULATED GASOLINE. Journal of Toxicology and Environmental Health. 47(5). 453–464. 22 indexed citations
3.
Hutcheon, Duncan E., et al.. (1991). A Computer‐Based, Problem‐Solving System of Instruction in Clinical Pharmacology. The Journal of Clinical Pharmacology. 31(3). 198–204. 3 indexed citations
4.
Najem, G. Reza, Duncan E. Hutcheon, & Martin Feuerman. (1990). Changing Patterns of Ischaemic Heart Disease Mortality in New Jersey 1968–1982, and the Relationship with Urbanization. International Journal of Epidemiology. 19(1). 26–31. 15 indexed citations
5.
Hutcheon, Duncan E.. (1983). Joseph Seifter, M.D., F.C.P. 1904–1982. The Journal of Clinical Pharmacology. 23(1). 2–4. 2 indexed citations
6.
Hutcheon, Duncan E., et al.. (1981). Clinical Use of Diuretics in Congestive Heart Failure. The Journal of Clinical Pharmacology. 21(11). 668–672. 11 indexed citations
7.
Hutcheon, Duncan E., et al.. (1981). Renal Electrolyte Excretion Pattern in Response to Bumetanide in Healthy Volunteers. The Journal of Clinical Pharmacology. 21(11). 604–609. 13 indexed citations
8.
Duchin, Kenneth L. & Duncan E. Hutcheon. (1978). Distribution of intracortical renal blood flow induced by bumetanide in the dog.. Journal of Pharmacology and Experimental Therapeutics. 204(1). 135–140. 15 indexed citations
9.
Duchin, Kenneth L. & Duncan E. Hutcheon. (1977). Comparison of Bumetanide and Hydrochlorothiazide on Renal Potassium and Hydrogen Ion Excretion. The Journal of Clinical Pharmacology. 17(8-9). 453–460. 10 indexed citations
10.
Hutcheon, Duncan E.. (1976). THE JOURNAL OF CLINICAL PHARMACOLOGY. The Journal of Clinical Pharmacology. 16(4). 161–161. 70 indexed citations
11.
Hutcheon, Duncan E.. (1976). BENEFIT—RISK FACTORS ASSOCIATED WITH SUPPLEMENTAL POTASSIUM THERAPY. The Journal of Clinical Pharmacology. 16(2-3). 85–87. 12 indexed citations
12.
Hutcheon, Duncan E.. (1972). Factors Influencing the Growth of Clinical Pharmacology. PubMed. 12(10). 365–368. 1 indexed citations
13.
Hutcheon, Duncan E.. (1972). ROLE OF CLINICAL PHARMACOLOGY IN THE MEDICAL CURRICULUM. PubMed. 12(1). 3–4. 2 indexed citations
14.
Hutcheon, Duncan E.. (1971). The Pharmacological Basis of Therapeutics, 4th Edition. Louis S. Goodman and Alfred Gilman. 11(5). 388–388. 1 indexed citations
15.
Hutcheon, Duncan E., et al.. (1962). Antihypertensive Action of Diazoxide. BMJ. 2(5298). 159–161. 27 indexed citations
16.
Hutcheon, Duncan E., Alexander Scriabine, & Daniel L. Morris. (1956). CARDIOVASCULAR ACTION OF HYDROXYZINE (ATARAX). Journal of Pharmacology and Experimental Therapeutics. 118(4). 451–460. 23 indexed citations
17.
Pan, Sharon, et al.. (1955). General anesthetic and other pharmacological properties of a soluble steroid, 21-hydroxypregnanedione sodium succianate.. PubMed. 115(4). 432–41. 22 indexed citations
18.
Hutcheon, Duncan E., et al.. (1955). THE SYMPATHOMIMETIC AND OTHER PHARMACOLOGICAL PROPERTIES OF DL 2-(1 ,2 ,3 ,4-TETRAHYDRO-1-NAPHTHYL)-IMIDAZOLINE (TETRAHYDROZOLINE). Journal of Pharmacology and Experimental Therapeutics. 113(3). 341–352. 6 indexed citations
19.
Pan, Sharon, et al.. (1955). GENERAL ANESTHETIC AND OTHER PHARMACOLOGICAL PROPERTIES OF A SOLUBLE STEROID, 21-HYDROXYPREGNANEDIONE SODIUM SUCCINATE. Journal of Pharmacology and Experimental Therapeutics. 115(4). 432–441. 13 indexed citations
20.
Hutcheon, Duncan E.. (1953). A COMPARISON OF THE PHARMACOLOGICAL ACTIONS OF PHENOTHIAZINE DERIVATIVES USED IN THE TREATMENT OF PARKINSONISM. Journal of Pharmacology and Experimental Therapeutics. 108(3). 340–348. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026